Clinical Trial Update: A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) [Phase 2]

View source ↗

Summary

Ongoing Phase 2b trial evaluating oral VH4524184 regimens in treatment-naive HIV-1 patients (INNOVATE) and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• VH4524184

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 2 | Status: RECRUITING